Neurock Pharmaceuticals
Neurock Pharmaceuticals is a startup headquartered in Princeton, United States, founded in 2022. It has raised at least $10.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory. Last updated .
Funding
Neurock Pharmaceuticals has raised at least $10.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Neurock Pharmaceuticals sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in Princeton
- Antigenix Therapeutics
- Aruka Bio
- Evermore Technologies
- Populus Media
- Rhodenergy An Environmental Co
- Ricovr Healthcare
- Ventis Medical
Related
- Innovation profile of Princeton
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Neurock Pharmaceuticals do?
Neurock Pharmaceuticals is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Neurock Pharmaceuticals raised?
At least $10.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Neurock Pharmaceuticals based?
Neurock Pharmaceuticals is headquartered in Princeton, United States.
When was Neurock Pharmaceuticals founded?
Neurock Pharmaceuticals was founded in 2022.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.